Bengaluru (Karnataka) [India], September 9 (ANI/BusinessWire India): Antimicrobial resistance (AMR) and the increase of multi-resistant bacteria is an ongoing threat to global public health, as the World Health Organization (WHO) warns. In 2019, 1.27 million people died from antibiotic-resis
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
New Delhi [India], June 24 (ANI): COVID-19 vaccination drive in India prevented over 42 lakh deaths in 2021, according to the Lancet Infectious Diseases journal, which is based on findings on estimates of "excess" mortalities in the country during the pandemic.
New Delhi [India], May 12 (ANI): Two years after getting infected with COVID-19, health outcomes of people who have suffered hospitalisation, reported at least one symptom, said a follow-up study by The Lancet medical journal on Thursday.
New Delhi [India], March 2 (ANI): Dismissing the Lancet reports giving details of children affected by COVID-19 associated orphanhood, Union Minister for Women and Child Development Smriti Irani on Wednesday said that these findings have no correlation with ground reality in India as reflect
Washington [US], February 26 (ANI): A new study, released in The Lancet Respiratory Medicine by Providence, confirmed the overall effectiveness of vaccines in preventing severe infection resulting in hospitalisation from COVID-19. But the study also showed a substantial decline in protection
New Delhi [India], December 23 (ANI): The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Moscow [Russia], September 13 (ANI): The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) has announced the publication of a study in EClinicalMedicine (an open access peer-reviewed clinical journal published by The Lancet, one of the world's most respected medical journ
New Delhi [India], July 14 (ANI): The contribution of non-communicable neurological disorders and neurological injuries to the total disease burden has more than doubled between 1990 and 2019, finds the India State-Level Disease Burden Initiative in a paper published in The Lancet Global Hea